Company Information

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE362.85-1.9 (-0.52 %)
PREV CLOSE ( ) 364.75
OPEN PRICE ( ) 364.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8504
TODAY'S LOW / HIGH ( )358.65 364.80
52 WK LOW / HIGH ( )257.05 401
NSE362.70-1.35 (-0.37 %)
PREV CLOSE( ) 364.05
OPEN PRICE ( ) 366.00
BID PRICE (QTY) 362.70 (29)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99352
TODAY'S LOW / HIGH( ) 358.40 366.05
52 WK LOW / HIGH ( )258 401
ChairmanB S Ajai Kumar
Company SecretarySunu Manuel
Executive DirectorAnjali Rossi Ajaikumar
Nominee DirectorSiddharth Patel
Amit Soni
Non Executive Independent DirectorGeeta Mathur
Rajagopalan Raghavan
Jeyandran Venugopal
Pradip Kanakia
Rajiv Mailwal
Whole Time DirectorMeghraj Arvindrao Gore
Incorporation Year : 1998

Registered Office :

Address : H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar Bengaluru,
Karnataka-560027 .

Phone : 080 - 33669999

Email :  info@hcgoncology.com 

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.